Prof. Dr. Bülent Karabulut

Real-world practices in RAS wild-type metastatic colorectal cancer patients treated with targeted agents in the first-line a nationwide onco-colon Turkey registry

Anadolu Kliniği Tıp Bilimleri Dergisi, 2026

DOI 10.21673/anadoluklin.1675424 Texte intégral en libre accèsSource : OpenAlex

Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study

Cancers, 2026

DOI 10.3390/cancers18121979 PMID 42352512 Texte intégral en libre accèsSource : OpenAlex

Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature

Clinical Genitourinary Cancer, 2026

DOI 10.1016/j.clgc.2026.102594 PMID 42349378 Source : OpenAlex

Prognostic and Treatment-Specific Predictive Implications of HER2 Expression in RAS Wild-Type Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Study

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15103979 PMID 42194940 Texte intégral en libre accèsSource : OpenAlex

Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Right-Sided RAS/RAF Wild-Type Metastatic Colorectal Cancer: A Real-World Multicenter Cohort Study

Clinics and Practice, 2026

DOI 10.3390/clinpract16090158 PMID 42783081 Texte intégral en libre accèsSource : OpenAlex

Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

Current Oncology, 2026

DOI 10.3390/curroncol33060365 PMID 42346265 Texte intégral en libre accèsSource : OpenAlex

Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15020467 PMID 41598406 Texte intégral en libre accèsSource : ORCID

Association Between Preoperative Albumin-to-Globulin Ratio (AGR) and Recurrence-Free Survival in High-Risk Resected Cutaneous Melanoma

Eurasian Journal of Medical Investigation, 2026

DOI 10.14744/ejmi.2612540 Source : ORCID

Impact of oral nutritional support adherence on muscle strength, body composition, and general health status in gastrointestinal cancer patients: ONMUS study

Nutrition, 2026

DOI 10.1016/j.nut.2025.113029 PMID 41455457 1 citation (Europe PMC) Source : ORCID

Evaluation of Olaparib Efficacy Following CDK4/6 Inhibitor Therapy in BRCA-Mutated, Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Turkish Oncology Group (TOG) Study

Targeted Oncology, 2026

DOI 10.1007/s11523-026-01261-w PMID 42907609 Source : OpenAlex

Prognostic Value of the Vitamin B12/C-Reactive Protein Index in Resected Stage II–III Cutaneous Melanoma: Comparison with Its Individual Components

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15155759 PMID 42589863 Texte intégral en libre accèsSource : OpenAlex

Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study

Cancer Investigation, 2025

DOI 10.1080/07357907.2025.2595536 PMID 41347635 1 citation (Europe PMC) Source : OpenAlex

KRAS Mutasyonu Saptanmayan Metastatik Kolorektal Kanserli Hastalarda Anti-EGFR Kullanımı-Ulusal Onco-Colon Çalışması Gerçek Yaşam Verleri

DergiPark (Istanbul University), 2025

Source : OpenAlex

P044: Examining the Correlation and Concordance Between Ki-67 Expression and Oncotype DX Recurrence Score: Findings from a Multicenter Study in Turkey

The Breast, 2025

DOI 10.1016/j.breast.2025.103928 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Perineural and Lymphovascular Invasion in Resected Pancreatic Ductal Adenocarcinoma: A High-Risk Subgroup That Could Benefit from Adjuvant Radiotherapy

Journal of Clinical Medicine, 2025

DOI 10.3390/jcm14217763 PMID 41227159 Texte intégral en libre accèsSource : OpenAlex

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC

Journal of Oncology Pharmacy Practice, 2024

DOI 10.1177/10781552241241004 PMID 38613329 Texte intégral en libre accèsSource : OpenAlex

Alterations in muscle strength among patients with GI cancers receiving oral nutritional support as soon as malnutrition was detected: ONMUS study.

Journal of Clinical Oncology, 2024

DOI 10.1200/jco.2024.42.3_suppl.741 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Is there a role for cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from unusual types of cancer?

European Journal of Surgical Oncology, 2024

DOI 10.1016/j.ejso.2023.107866 Source : OpenAlex

Long-Term Survival in a Patient with Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil as Late-Line Chemotherapy: A Case Report

Case Reports in Oncology, 2024

DOI 10.1159/000535202 PMID 38988695 Texte intégral en libre accèsSource : OpenAlex

Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study

Cureus, 2023

DOI 10.7759/cureus.39119 PMID 37216135 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Genetic testing in patients with pancreatic cancer to reveal pathogenic variants in cancer susceptibility genes.

Journal of Clinical Oncology, 2023

DOI 10.1200/jco.2023.41.16_suppl.e16276 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study

Journal of Chemotherapy, 2022

DOI 10.1080/1120009x.2022.2073159 PMID 35579894 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

P-90 First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis

Annals of Oncology, 2022

DOI 10.1016/j.annonc.2022.04.180 Texte intégral en libre accèsSource : OpenAlex

Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey

Future Oncology, 2022

DOI 10.2217/fon-2022-0455 PMID 36040321 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Chemotherapy Choice in Neoadjuvant Dual Her2 Blockade; Is It Really Necessary to Add Anthracycline?

Research Square, 2022

DOI 10.21203/rs.3.rs-531944/v2 Texte intégral en libre accèsSource : ORCID

Surgical, pathological and clinical features of advanced collorectal cancers with metastasectomy. "Onco-Colon Turkey Registry" real-life data.

Journal of Clinical Oncology, 2022

DOI 10.1200/jco.2022.40.4_suppl.299 Source : OpenAlex

Effect of interval between neoadjuvant chemoradiotherapy and surgery on disease recurrence and survival in rectal cancer: long-term results of a randomized clinical trial

BJS Open, 2022

DOI 10.1093/bjsopen/zrac107 PMID 36254732 15 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Peritoneal Metastases From Prostate Adenocarcinoma – A Case Report

Malaysian Journal of Medicine and Health Sciences, 2022

DOI 10.47836/mjmhs.18.s13.8 Texte intégral en libre accèsSource : OpenAlex

The Effect of Insulin Therapy on Serum Osteocalcin Levels in Type II Diabetic Men

DOAJ (DOAJ: Directory of Open Access Journals), 2022

Texte intégral en libre accèsSource : OpenAlex

P-219 Real-life experience with chemotherapy plus biologics in first-line treatment of right-sided, RAS wild-type, metastatic colon cancer: A multicenter Onco-Colon Turkey study

Annals of Oncology, 2021

DOI 10.1016/j.annonc.2021.05.273 Texte intégral en libre accèsSource : OpenAlex

Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer.

Journal of Clinical Oncology, 2021

DOI 10.1200/jco.2021.39.15_suppl.e15561 Source : OpenAlex

A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients with HER2-positive Gastric or Gastroesophageal Junction Cancer (TOXAG Study): A Turkish Oncology Group Study

American Journal of Clinical Oncology: Cancer Clinical Trials, 2021

DOI 10.1097/coc.0000000000000825 PMID 33979100 17 citations (Europe PMC) Source : ORCID

Chemotherapy Choice in Neoadjuvant Dual Her2 Blockade; is it Really Necessary to add Anthracycline?

Research Square, 2021

DOI 10.21203/rs.3.rs-531944/v1 Texte intégral en libre accèsSource : ORCID

Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES

Breast Cancer Research and Treatment, 2021

DOI 10.1007/s10549-021-06173-z PMID 33728524 20 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study

BMC Cancer, 2021

DOI 10.1186/s12885-021-08738-z PMID 34521387 15 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Older adults with colon cancer are not different from younger ones, but treated differently: Retrospective analysis from single centre

Journal of Oncology Pharmacy Practice, 2021

DOI 10.1177/10781552211002912 PMID 33752476 3 citations (OpenAlex) Source : OpenAlex

Contribution of “complete response to treatment” to survival in patients with unresectable metastatic colorectal cancer: A retrospective analysis

PLoS ONE, 2021

DOI 10.1371/journal.pone.0259622 PMID 34748587 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Prospective Observational Study on Pazopanib in Patients Treated for Advanced or Metastatic Renal Cell Carcinoma in Countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE Study

Research Square, 2021

DOI 10.21203/rs.3.rs-443033/v1 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Biomarkers in Bone Metastases

Turkish Journal of Oncology, 2021

DOI 10.5505/tjo.2021.s1004 Texte intégral en libre accèsSource : OpenAlex

Bone-targeted Therapies for Prostate Cancer

Turkish Journal of Oncology, 2021

DOI 10.5505/tjo.2021.s1014 Texte intégral en libre accèsSource : OpenAlex

Abstract P5-11-19: Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey

Cancer Research, 2020

DOI 10.1158/1538-7445.sabcs19-p5-11-19 Source : OpenAlex

Ege Ünıversıtesı hastanesı veri tabanındaki mide kanserlerinin epidemiyolojisi ve sağkalım özellikleri

Ege Tıp Dergisi, 2020

DOI 10.19161/etd.815041 Texte intégral en libre accèsSource : OpenAlex

A Phase Ii Study Of The Combination Of Oxaliplatin, Capecitabine, And Trastuzumab And Chem-oradiotherapy In The Adjuvant Setting In Operated Patients With Her2+ Gastric Or Gastroesophageal Junction Cancer (Toxag Study), A Turkish Oncology Group Study

Research Square, 2020

DOI 10.21203/rs.3.rs-16111/v1 Texte intégral en libre accèsSource : ORCID

Ege Üniversitesi hastanesi veri tabanındaki pankreas kanserlerinin epidemiyolojik ve genel sağkalım özellikleri

Ege Tıp Dergisi, 2020

DOI 10.19161/etd.814910 1 citation (OpenAlex) Texte intégral en libre accèsSource : ORCID

Ege Ünı̇ versı̇tesı̇ hastanesı̇ veri tabanındaki özofagus kanserlerinin epidemiyolojisi ve sağkalım özellikleri

Ege Tıp Dergisi, 2020

DOI 10.19161/etd.815112 Texte intégral en libre accèsSource : ORCID

Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study

BMC Cancer, 2020

DOI 10.1186/s12885-020-06758-9 PMID 32228512 11 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

The effectiveness of cetuximab and panitumumab when combined with FOLFIRI in second-line treatment of KRAS wild type metastatic colorectal cancers. Single centre experience

Journal of Chemotherapy, 2020

DOI 10.1080/1120009x.2020.1861531 PMID 33349195 2 citations (OpenAlex) Source : OpenAlex

Ege Üniversitesi hastanesinde prostat kanserlerinin epidemiyolojisi ve genel sağkalım özellikleri

Ege Tıp Dergisi, 2020

DOI 10.19161/etd.815093 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Abstract A27: The relationship between aspirin and cancer via its inhibition of mTOR pathway

Molecular Cancer Research, 2020

DOI 10.1158/1557-3125.pi3k-mtor18-a27 Source : OpenAlex

204P Prospective observational study on pazopanib in patients treated for advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: Final analysis of PARACHUTE study

Annals of Oncology, 2020

DOI 10.1016/j.annonc.2020.10.216 Texte intégral en libre accèsSource : OpenAlex